P.A.W. Capital Corp Cellectis S.A. Transaction History

P.A.W. Capital Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 06, 2019	SELL	$15.58 - $28.41 $623,200 - $1.14 Million	-40,000 Closed	0 $0
Q2 2018 Jul 25, 2018	BUY	$27.78 - $38.53 $736,170 - $1.02 Million	26,500 Added 196.3%	40,000 $1.13 Million
Q1 2018 Apr 26, 2018	BUY	$27.78 - $35.19 $375,030 - $475,064	13,500 New	13,500 $425,000

10.8M

5.9K

1.4K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $71M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of P.A.W. Capital Corp, based on Form 13F filings with the SEC.

Stay updated on P.A.W. Capital Corp with notifications on news.